Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6,100
Frequently Asked Questions
What is Market Cap of Vertex Pharmaceuticals, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vertex Pharmaceuticals, Inc. market cap is $97.91B.
What is the 52-week high for Vertex Pharmaceuticals, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vertex Pharmaceuticals, Inc. 52 week high is $519.88 as of September 26, 2025.
What is the 52-week low for Vertex Pharmaceuticals, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vertex Pharmaceuticals, Inc. 52 week low is $362.50 as of September 26, 2025.
What is Vertex Pharmaceuticals, Inc. stock price today?
Vertex Pharmaceuticals, Inc. stock price today is $385.45.
What was Vertex Pharmaceuticals, Inc. stock price yesterday?
Vertex Pharmaceuticals, Inc. stock price yesterday was $381.87.
What is the PE ratio of Vertex Pharmaceuticals, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vertex Pharmaceuticals, Inc.’s P/E ratio is 27.30.
What is the Price-to-Book ratio of Vertex Pharmaceuticals, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vertex Pharmaceuticals, Inc. P/B ratio is 5.6983.
What is the 50-day moving average of Vertex Pharmaceuticals, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vertex Pharmaceuticals, Inc. 50-day moving average is $408.93.
How many employess does Vertex Pharmaceuticals, Inc. has?
VRTX Vertex Pharmaceuticals, Inc.